Skip to content
Use caution Drug recall · FDA · Published August 28, 2014

Fougera Recalls Fluocinonide Gel Due to Stability Failures

Fougera Pharmaceuticals recalls specific lots of Fluocinonide Gel USP 0.05% due to failed stability specifications regarding residual solvents.

🇺🇸 FDA recall #D-0245-2015DrugFougera Pharmaceuticals ›
Take action

Contact the company

Recalling firmFougera Pharmaceuticals Inc.60 Baylis Rd · Melville, NY 11747-3838
✎ GovInfoNow plain-language explainer

Fougera Pharmaceuticals Inc. is recalling specific lots of Fluocinonide Gel USP, 0.05%, because the product may not meet requirements for residual solvents as outlined in USP <467>. This issue affects both 15-gram and 60-gram tubes distributed nationwide and in Puerto Rico. The recall was initiated on August 28, 2014. Read more at govinfonow.com/recall/45774-fougera-pharmaceuticals-inc-recalls-fluocinonide-gel-usp-0-05-rx.

Source Summary by GovInfoNow · govinfonow.com/recall/45774-fougera-pharmaceuticals-inc-recalls-fluocinonide-gel-usp-0-05-rx · Updated October 12, 2026 · FDA enforcement record: FDA #D-0245-2015

Cite this page

“Fougera Recalls Fluocinonide Gel Due to Stability Failures.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45774-fougera-pharmaceuticals-inc-recalls-fluocinonide-gel-usp-0-05-rx. Based on FDA recall #D-0245-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0245-2015%22&limit=1).

The FDA announced on 2014-08-28 that Fougera Pharmaceuticals Inc. is recalling Fluocinonide Gel USP, 0.05%, because the lots may not meet residual solvent specifications. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Fougera Pharmaceuticals
  • Product: Fluocinonide Gel USP, 0.05%
  • NDC 0168-0135-15 (15 g tubes)
  • NDC 0168-0135-60 (60 g tubes)
  • 15 gram lot numbers: 549N, 550N, 551N, EB1961
  • 60 gram lot numbers: 546N, 547N, 548N, EB0144
  • Sold nationwide and in Puerto Rico

The hazard

The recalled lots of Fluocinonide Gel USP may not meet the requirements for residual solvents as outlined in USP , according to the FDA.

Context

GovInfoNow's records show Fougera Pharmaceuticals Inc. has 6 other recalls on record since 2012-06-07. Other recent recalls of similar products include Sun Pharmaceutical Fluocinonide Cream Recall (2026-03-25) and Wells Pharma Fentanyl Citrate Injectable Solution Recall (2026-04-01).

How to tell if you have this one

Check your tube for the NDC number 0168-0135-15 (15 g) or 0168-0135-60 (60 g). Verify the lot numbers and expiration dates: 15 g lots include 549N, 550N, 551N (Exp. 1/2015), EB1961 (Exp. 2/2017); 60 g lots include 546N, 547N, 548N (Exp. 1/2015), EB0144 (Exp. 2/2017).

  • Brand
    Fougera Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product Details

    Verify if your Fluocinonide Gel matches the recalled NDC numbers and lot numbers listed in the record.

  2. Contact Your Pharmacist or Provider

    Since the remedy is not stated in the record, consult your healthcare provider or pharmacist for instructions on how to proceed with the recalled medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Aug 28, 201412. FDA classified it Class II: Nov 12, 201423. Published in FDA’s Enforcement Report: Nov 19, 201434. FDA terminated the recall: Jun 21, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0245-2015 (August 28, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0245-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA